Pressmeddelanden, rapporter och bolagsmeddelande för Peptonic Medical
Press release from Companies: Nyttjandeperiod för teckningsoptioner av serie TO3 inleds idag
Press release from Companies: The exercise period for warrants of series TO3 starts today
Press release from Companies: The subscription price for the warrants of series TO3 in PEPTONIC medical AB has been determined to SEK 0.05 and the exercise period starts November 2, 2023
Press release from Companies: Teckningskursen för teckningsoptioner av serie TO3 i PEPTONIC medical AB har fastställts till 0,05 SEK och nyttjandeperioden inleds den 2 november 2023
Press release from Companies: Peptonics VD Erik Sundquist intervjuas av Finwire.tv
Press release from Companies: Peptonic to present at BioStock Life Science Fall Summit on October 26
Press release from Companies: Peptonic presenterar på BioStock Life Science Fall Summit den 26 oktober
Press release from Companies: Peptonic presenterar på BioStock Life Science Fall Summit den 26 oktober
Reports: PEPTONIC Medical AB (publ), QUARTERLY REPORT Period January – September 2023
Reports: PEPTONIC Medical AB (publ), QUARTERLY REPORT Period January – September 2023